Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 4, 2025
- Accession no.
- 0001673232-25-000002
- Filed
- Sep 4, 2025
- Trade date
- Sep 1-2, 2025
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 18 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.40M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | MOption exerciseAcquired | +14,625 | $135.42 | +$1,980,517.5 | 14,625 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −11,375 | $419.63 | −$4,773,291.25 | 3,250 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −106 | $405.59 | −$42,992.54 | 3,144 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −500 | $407.34 | −$203,670 | 2,644 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −700 | $408.97 | −$286,279 | 1,944 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −1,144 | $409.97 | −$469,005.68 | 800 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −168 | $412.69 | −$69,331.92 | 632 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −32 | $413.39 | −$13,228.48 | 600 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −200 | $416.30 | −$83,260 | 400 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −328 | $418.03 | −$137,113.84 | 72 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −72 | $419.35 | −$30,193.2 | 0 | Indirect | |
| Sep 1, 2025 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −888 | $407.26 | −$361,646.88 | 6,987 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −300 | $408.28 | −$122,484 | 6,687 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −100 | $410.35 | −$41,035 | 6,587 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −367 | $417.45 | −$153,204.15 | 6,220 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −95 | $419.61 | −$39,862.95 | 6,125 | Indirect | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −6,125 | $419.63 | −$2,570,233.75 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 172,875 | Indirect | |
| Sep 2, 2025 | Common Stock | MOption exerciseDisposed | −7,875 | $0.00 | $0 | 55,125 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.